CART-PSMA-TGFβRDN Cells

· University of Pennsylvania

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CART-PSMA-TGFβRDN Cells, covering 2026-02-23 to 2026-02-23. Get the full timeline:

Most recent: Clinical Trial Update: CART-PSMA-TGFβRDN Cells for Castrate-Resistant Prostate Cancer [Phase 1]